Reaction Details |
| Report a problem with these data |
Target | Isocitrate dehydrogenase [NADP] cytoplasmic |
---|
Ligand | BDBM383860 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1859394 (CHEMBL4360250) |
---|
IC50 | 1.000000±n/a nM |
---|
Citation | Lin, J; Lu, W; Caravella, JA; Campbell, AM; Diebold, RB; Ericsson, A; Fritzen, E; Gustafson, GR; Lancia, DR; Shelekhin, T; Wang, Z; Castro, J; Clarke, A; Gotur, D; Josephine, HR; Katz, M; Diep, H; Kershaw, M; Yao, L; Kauffman, G; Hubbs, SE; Luke, GP; Toms, AV; Wang, L; Bair, KW; Barr, KJ; Dinsmore, C; Walker, D; Ashwell, S Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. J Med Chem62:6575-6596 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Isocitrate dehydrogenase [NADP] cytoplasmic |
---|
Name: | Isocitrate dehydrogenase [NADP] cytoplasmic |
Synonyms: | Cytosolic NADP-isocitrate dehydrogenase | IDH | IDH1 | IDHC_HUMAN | IDP | Isocitrate Dehydrogenase (IDH1) | Isocitrate dehydrogenase 1 (IDH1) | NADP(+)-specific ICDH | Oxalosuccinate decarboxylase | PICD |
Type: | Protein |
Mol. Mass.: | 46661.29 |
Organism: | Homo sapiens (Human) |
Description: | O75874 |
Residue: | 414 |
Sequence: | MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDA
AEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRL
VSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAM
GMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFE
AQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDG
KTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALE
EVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
|
|
|
BDBM383860 |
---|
n/a |
---|
Name | BDBM383860 |
Synonyms: | US10280150, Cmpd No I-143 | US10550099, Compound I-143 |
Type | Small organic molecule |
Emp. Form. | C18H16ClN5O3 |
Mol. Mass. | 385.804 |
SMILES | COc1cc2[nH]c(=O)c(cc2cc1Cl)[C@H](C)Nc1ncc(C#N)c(OC)n1 |r| |
Structure |
|